Achaemenid Innovations’ wireless oral cavity sensor detects oxygen saturation, pulse rate, actigraphy, and oral appliance use, aiming to overcome skin-tone and environmental limitations of fingertip oximetry.
Achaemenid Innovations LLC has been granted a new patent for wireless intraoral oximetry via its proprietary biosensor technology.
The biosensor is designed to detect pulse rate and oxygen saturation from the vascular soft tissue of the oral cavity. According to Achaemenid Innovations founder Reza Radmand, DMD, FAAOM, the oral cavity offers considerable advantages over traditional access sites like the fingertip, such as:
- stable core temperature,
- no ambient light pollution,
- reduce melanin impact on individuals with darker skin, and
- considerable proximity to the heart.
“This milestone highlights the brilliance, perseverance, and innovative thinking of our scientific and engineering team,” Radmand says. “At Achaemenid Innovations and iNOS Technologies, our mission is to equip the field of sleep medicine with the most advanced medical-grade biosensors, delivering continuous, objective, and robust physiological data.”
The proprietary optical module design behind the iNOS biosensor enables detection of even subtle changes in photoplethysmography signals, according to Radmand.
It integrates a six-axis inertial measurement unit for detecting actigraphy, body motion, and head position. It also records objective compliance monitoring of oral appliance usage.
The intra-oral oximetry device is just the first of a modular platform of biosensors and related products being developed by Achaemenid Innovations.
